Research on CD19‐positive lymphoid tumours has demonstrated that CAR‐NK cells derived from cord blood can produce potent antitumor activity (Cany et al., 2013; Liu et al., 2018). The gene discussed is CD19; the disease is lymphoid neoplasm.